LXEO
insider transactionsLexeo Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-73.6K
0 buy · 73.6K sell
Net value · 365d
-$427.6K
$0 in · $427.6K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
6
0 buy · 73.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Chief Operating Officer
$6.6K
1.3K sh · $5.07
Own -1%
-
Sell·S
Chief Executive Officer
$16.9K
3.3K sh · $5.06
Own -1%
-
Grant·A
Director
$0
50.0K sh
Own New
-
Sell·S
Chief Executive Officer · 10b5-1
$313.1K
55.0K sh · $5.69
Own -14%
-
Grant·A
Chief Operating Officer
$15.7K
5.9K sh · $2.64
Own +5%
-
Grant·A
Chief Executive Officer
$6.9K
2.6K sh · $2.64
Own +1%
-
Sell·S
Chief Operating Officer
$19.3K
3.0K sh · $6.40
Own -2%
-
Sell·S
Chief Executive Officer
$64.9K
10.2K sh · $6.38
Own -3%
-
Grant·A
Chief Medical Officer
$0
297.0K sh
Own New
-
Grant·A
Chief Medical Officer
$0
49.5K sh
Own New
-
Grant·A
Chief Financial Officer
$0
226.7K sh
Own New
-
Grant·A
Chief Financial Officer
$0
44.7K sh
Own +99%
-
Grant·A
Chief Operating Officer
$0
260.0K sh
Own New
-
Grant·A
Chief Operating Officer
$0
65.0K sh
Own +102%
-
Grant·A
Chief Executive Officer
$0
646.7K sh
Own New
-
Grant·A
Chief Executive Officer
$0
161.7K sh
Own +67%
-
Sell·S
Chief Operating Officer
$6.7K
721 sh · $9.27
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 18, 2026 | Jose Manuel Otero | Sell S | 1.3K | $6.6K |
| May 18, 2026 | Richard Nolan Townsend KEY | Sell S | 3.3K | $16.9K |
| Apr 28, 2026 | Laura Sepp-Lorenzino | Grant A | 50.0K | $0 |
| Apr 6, 2026 | Richard Nolan Townsend KEY 10b5-1 | Sell S | 55.0K | $313.1K |
| Mar 13, 2026 | Jose Manuel Otero | Grant A | 5.9K | $15.7K |
| Mar 13, 2026 | Richard Nolan Townsend KEY | Grant A | 2.6K | $6.9K |
| Feb 18, 2026 | Jose Manuel Otero | Sell S | 3.0K | $19.3K |
| Feb 18, 2026 | Richard Nolan Townsend KEY | Sell S | 10.2K | $64.9K |
| Feb 13, 2026 | Narinder Pal Bhalla | Grant A | 297.0K | $0 |
| Feb 13, 2026 | Narinder Pal Bhalla | Grant A | 49.5K | $0 |
| Feb 4, 2026 | Louis Edward Tamayo KEY | Grant A | 226.7K | $0 |
| Feb 4, 2026 | Louis Edward Tamayo KEY | Grant A | 44.7K | $0 |
| Feb 4, 2026 | Jose Manuel Otero | Grant A | 260.0K | $0 |
| Feb 4, 2026 | Jose Manuel Otero | Grant A | 65.0K | $0 |
| Feb 4, 2026 | Richard Nolan Townsend KEY | Grant A | 646.7K | $0 |
| Feb 4, 2026 | Richard Nolan Townsend KEY | Grant A | 161.7K | $0 |
| Nov 18, 2025 | Jose Manuel Otero | Sell S | 721 | $6.7K |
About LXEO insider trading
This page tracks insider transactions for Lexeo Therapeutics, Inc. (LXEO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.